Secure Access Management for Life Sciences: Simplifying Access Across Clinical Applications
A clinical site user on an active study may sign into more than 11 different applications before they get started with the day’s real work. It’s likely each one was issued by a different sponsor or vendor, with authentication credentials the user has to manage. The Society for Clinical Research Sites found that too many systems with separate logins are among the biggest technology obstacles sites face.
That friction slows studies and inflates cost, not to mention causing frustration for the team. Beyond adding friction, every credential creates security and compliance risks. Each one is an opportunity to grant access to the wrong person or fail to revoke when a study is complete.
Exostar Secure Access Manager minimizes the friction and the risk by giving each authorized person a single trusted login for all of the applications and sites they need.
What Is Secure Access Management in Clinical Trials?
Secure access management is the practice of controlling and simplifying how people access the clinical and research applications used in a trial. It ensures the right users gain access quickly while sensitive data stays protected.
Conventional identity and access management (IAM) systems are designed for a single enterprise governing its own employees inside its own systems. Clinical trials don’t work that way. The teams leading the study belong to a site, while the software they use belongs to many separate sponsors and contract research organizations (CRO).
Secure access management brings the simplicity of IAM to ecosystems that share access across many different individuals and organizations. Within Exostar’s network of more than 920,000+ users across 36,000 organizations, a site’s users get one verified identity with each sponsor rather than creating a new one each time.
Why Access Breaks Down Across the Life Sciences Ecosystem
A single study brings together sponsors, contract research organizations, and clinical sites that share the work. They have the study in common, but access management fragments across multiple individuals and organizations.
- Many organizations contribute to one study, and each manages its own users and systems, so no single party holds authority over who can access what.
- Every application is provisioned by the organization that owns it, so a single person accumulates a separate login for each system the study requires.
- A person verified by their own organization still has to be recognized by every sponsor and vendor whose systems they use.
- Studies open, change teams, and close, and access has to be granted and withdrawn continually across organizations without a common directory.
- Because no shared party vouches for an identity, the same person is verified again every time they join a new sponsor or study.
The Cost of Fragmented Access
Identity management issues are felt most keenly at the study site. Time is lost to password resets and waiting on a central help desk before a new study can start. Onboarding delays push back first-patient dates and the overall study timelines.
Perhaps most important for sponsors and CROs, high-friction access management imposes a cost that many sites will avoid if possible. Sites that come to regard a sponsor as difficult to work with may be reluctant to participate in that sponsor’s future trials.
How Single Sign-on and Federated Identity Management Simplify Clinical Trial Access
Two capabilities underlie Secure Access Management for the life sciences industry. Single sign-on governs the daily experience of logging in, while federated identity management determines whether an identity created by one organization can be trusted by another.
Single Sign-on for Everyday Access
Single sign-on lets an authorized user sign in once and access every application they are entitled to use. A dozen separate logins are replaced by a single trusted account.
Federated Identity Management Across Organizations
Federated identity allows the same verified account to be trusted by organizations that did not create it. When a sponsor recognizes a site user’s existing identity, they can use the associated credentials without creating new ones.
Because Exostar maintains a vetted community of identities that sponsors already trust, much of the verification work is done upfront, before a study begins. Onboarding that may have once taken weeks can be completed in hours.
How Secure Access Manager Supports Compliance and Audit Readiness
Regulators are highly motivated to ensure life sciences organizations can control who can access data and when. Frameworks such as 21 CFR Part 11 and the broader family of GxP quality regulations expect an organization to demonstrate that control rather than simply assert it.
Secure Access Manager gives organizations the tools they need to comply, including:
- Role-based permissions matched to each user’s role in the study
- An approval workflow that records the reason for every grant
- Automatic removal of access when a person’s role ends or a study closes
- A complete record of who accessed which application and when, so an audit can be answered with a report rather than a reconstruction
Exostar Secure Access Manager Is Built for the Realities of Clinical Research
Exostar Secure Access Manager was built for how clinical research actually operates, not adapted from a tool meant for corporate networks:
- One verified identity for every cleared sponsor application, reused with each sponsor rather than reissued.
- Access is granted to an identity that already exists in the community rather than being created from scratch.
- Delegated administration, so site and sponsor teams manage their own users rather than waiting on a central queue.
- A reporting trail that supports the life sciences audit and compliance requirements.
Exostar connects the sponsors, CROs, and sites that make up the life sciences community. With Secure Access Manager, studies get underway faster with less friction.
Talk with our team about what simpler, more secure access could mean for your next study.
Secure Access Manager FAQ
Secure Access Manager is Exostar’s cloud platform that gives each user in the life sciences community one verified identity for accessing the clinical applications a study relies on. Rather than managing a separate login for every sponsor system, an authorized user signs in once and uses every system they have been cleared to use.
Exostar Secure Access Manager replaces the many separate credentials a team would otherwise manage with a single trusted sign-in to every authorized application. Because the identity is already recognized throughout Exostar’s community, a user joining a new study reuses the access they already have rather than beginning the setup process again.
Single sign-on is the everyday convenience of signing in once to use many applications. Federated identity is the underlying trust mechanism, the part that lets one organization accept an identity that another organization created. Single sign-on is what a user experiences, while federation is what makes it work between organizations.
It enforces governed, role-based access and records the approval for every grant. When a role or a study ends, access is withdrawn automatically, and the resulting record shows who accessed which application and when, which is the kind of demonstrable control that 21 CFR Part 11 and broader GxP expectations call for.
Most site users already exist as verified identities within Exostar’s community, so onboarding becomes a matter of granting access rather than creating and vetting an account from scratch. A sponsor that removes that delay enrolls its first patient sooner and earns a reputation as an easier organization for strong sites to work with.
